Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophagogastric Adenocarcinoma”

172 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 172 results

Testing effectiveness (Phase 2)UnknownNCT02177552
What this trial is testing

Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
Rigshospitalet, Denmark 98
Not applicableStudy completedNCT03429816
What this trial is testing

OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma

Who this might be right for
Gastric NeoplasmGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma+2 more
University Hospital Heidelberg 120
Not applicableLooking for participantsNCT04443478
What this trial is testing

Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer

Who this might be right for
Gastric Cancer
Peking University 1,036
Large-scale testing (Phase 3)Looking for participantsNCT05978050
What this trial is testing

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd. 354
Testing effectiveness (Phase 2)Active Not RecruitingNCT05504720
What this trial is testing

Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma

Who this might be right for
Esophagogastric Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06469060
What this trial is testing

Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 34
Not applicableLooking for participantsNCT06158919
What this trial is testing

PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer

Who this might be right for
Gastric Cancer/Adenocarcinoma of Esophagogastric Junction
Fudan University 58
Testing effectiveness (Phase 2)Looking for participantsNCT06461910
What this trial is testing

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerEsophagogastric Junction Adenocarcinoma
Zekuan Xu 30
Testing effectiveness (Phase 2)Study completedNCT00737373
What this trial is testing

Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer

Who this might be right for
Gastric CancerAdenocarcinoma of the Esophagogastric Junction
Krankenhaus Nordwest 143
Not applicableLooking for participantsNCT07142122
What this trial is testing

Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 76
Large-scale testing (Phase 3)UnknownNCT01015339
What this trial is testing

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Who this might be right for
Advanced Gastric Cancer
Peking University 320
Not applicableLooking for participantsNCT06162767
What this trial is testing

Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis

Who this might be right for
Esophagogastric Junction Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 240
Testing effectiveness (Phase 2)UnknownNCT04263870
What this trial is testing

Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStomach AdenocarcinomaLocally Advanced Unresectable Gastric Adenocarcinoma+1 more
Sichuan University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05986227
What this trial is testing

The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):

Who this might be right for
Gastroesophageal Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT03443856
What this trial is testing

Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence

Who this might be right for
Gastric and Esophagogastric Junction Adenocarcinoma
European Organisation for Research and Treatment of Cancer - EORTC 197
Testing effectiveness (Phase 2)Looking for participantsNCT06123338
What this trial is testing

Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric AdenocarcinomaHER2 Gene Mutation
Memorial Sloan Kettering Cancer Center 49
Not applicableNot Yet RecruitingNCT07095699
What this trial is testing

Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study

Who this might be right for
Adenocarcinoma of the Esophagogastric Junction
Fudan University 314
Large-scale testing (Phase 3)UnknownNCT01468389
What this trial is testing

Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction

Who this might be right for
Gastric Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 300
Large-scale testing (Phase 3)UnknownNCT02512380
What this trial is testing

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

Who this might be right for
Gastric Adenocarcinoma
Chinese Academy of Medical Sciences 380
Testing effectiveness (Phase 2)Study completedNCT00004235
What this trial is testing

Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 47
Load More Results